MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Effects of deep brain stimulation on olfactory function in Parkinson’s disease

R. Cury, M. Carvalho, M.g. Santos Ghilardi, A. Estevo, A. de Paiva, F. Lopez, A. Coutinho, M. Teixeira, E. Barbosa, E. Fonoff (São Paulo, Brazil)

Meeting: 2017 International Congress

Abstract Number: 352

Keywords: Deep brain stimulation (DBS), Olfactory dysfunction, Parkinsonism

Session Information

Date: Monday, June 5, 2017

Session Title: Surgical Therapy: Parkinson’s Disease

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: The aim of this prospective study was to assess the impact of deep brain stimulation (DBS) on olfactory function in Parkinson’s disease (PD). 

Background: Non-motor symptoms (NMS) in PD are very commom and can be present from the early course of the disease. Smell dysfunction is one of the most present NMS, seen in at least 90% of patients, and leads to high disability and lower quality of life (1,2). 

Methods: Forty-six patients with PD and refractory motor symptoms were screened for subthalamic (STN) or globus pallidus internus (GPi) DBS. Patients were evaluated before and 1 year after surgery. Primary outcome was the change in olfactory function (Sniffin’ Sticks odor-identification test, SST) after surgery among the patients with hyposmia at baseline. Secondary outcomes included the relationship between motor outcomes and olfactory changes and the PET-SCAN analysis between subgroups with improvement vs no improvement of smell in the STN group.

Results: Baseline clinical characteristics are shown in [Table 1]. STN-DBS significantly improved SST after surgery when compared with baseline (preoperative SST, median 7.3 ± 2.4 vs postoperative, median 8.2 ± 2.1; p = 0.045) among 29/32 patients who presented hyposmia at baseline. The improvement in SST was positively correlated with the DBS response (r = 0.424; p = 0.035). There was no significantly change in SST after Gpi-DBS (preoperative SST, median 8.00 ± 2.35 vs postoperative, median 9.5 ± 2.5; p = 0.102) among 14/14 patients with hyposmia at baseline. The changes in SST was not correlated with motor outcomes in the Gpi group. The midbrain, cerebellum, anterior lobe, sub-gyral and right superior temporal gyrus were more activated in patients with SST improvement (p < 0.001) [Figure 1].

Conclusions: STN-DBS improves olfaction in PD patients. Motor improvement together with changes in the brain metabolism are the major determinants. Gpi-DBS showed no influence over olfactory function.

References: 1. Doty, R.L., Olfaction in Parkinson’s disease and related disorders. Neurobiol Dis, 2012. 46(3): p. 527-52.

2. Fonoff, E.T., et al., Pet findings in reversible improvement of olfactory dysfunction after STN stimulation in a Parkinson’s disease patient. Mov Disord, 2010. 25(14): p. 2466-8.

To cite this abstract in AMA style:

R. Cury, M. Carvalho, M.g. Santos Ghilardi, A. Estevo, A. de Paiva, F. Lopez, A. Coutinho, M. Teixeira, E. Barbosa, E. Fonoff. Effects of deep brain stimulation on olfactory function in Parkinson’s disease [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/effects-of-deep-brain-stimulation-on-olfactory-function-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/effects-of-deep-brain-stimulation-on-olfactory-function-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley